You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pulmozyme

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID Trial in Boston, Weymouth (Pulmozyme, Placebo)

Recruiting
  • COVID
  • Pulmozyme
  • Placebo
  • Boston, Massachusetts
  • +2 more
Dec 7, 2021

Ischemic Stroke Trial (Administration of dornase alfa)

Not yet recruiting
  • Ischemic Stroke
  • Administration of dornase alfa
  • (no location specified)
Apr 21, 2022

Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal

Not yet recruiting
  • Pleural Infection
  • Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
  • Saline irrigation with 250 mls normal saline (over 1 hour)
  • (no location specified)
Jun 19, 2023

Ischemic Stroke, Inflammatory Response Trial in Munich (Dornase Alfa, Isotonic Saline Solution)

Not yet recruiting
  • Ischemic Stroke
  • Inflammatory Response
  • Dornase Alfa
  • Isotonic Saline Solution
  • Munich, Bavaria, Germany
    Institute for Stroke and Dementia Research, Ludwig Maximilian Un
Jun 1, 2023

Loculated Empyema Trial in Cheras (Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg)

Completed
  • Loculated Empyema
  • Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg
  • Cheras, Kuala Lumpur, Malaysia
    University Kebangsaan Malaysia Medical Centre
Jun 4, 2021

COVID-19 Pneumonia Trial (Dornase Alfa, Saline)

Not yet recruiting
  • COVID-19 Pneumonia
  • (no location specified)
Dec 1, 2021

Cystic Fibrosis Trial in Tours (Pulmozyme)

Completed
  • Cystic Fibrosis
  • Pulmozyme
  • Tours, France
    University Hospital - Tours
Feb 28, 2022

Multiple Trauma, Respiratory Distress Syndrome, Adult Trial in Strasbourg (Dornase Alfa Inhalant Solution [Pulmozyme], Placebos)

Recruiting
  • Multiple Trauma
  • Respiratory Distress Syndrome, Adult
  • Dornase Alfa Inhalant Solution [Pulmozyme]
  • Placebos
  • Strasbourg, France
    University Hospital, Strasbourg, france
Jul 7, 2022

COVID19, Hypoxia Trial in London (Dornase Alfa Inhalation Solution [Pulmozyme])

Completed
  • COVID19
  • Hypoxia
  • Dornase Alfa Inhalation Solution [Pulmozyme]
  • London, United Kingdom
    University College London Hospital
Nov 8, 2021

COVID-19, Acute Respiratory Distress Syndrome Trial in Paris (Dornase Alfa Inhalation Solution [Pulmozyme], standard procedure)

Terminated
  • COVID-19
  • Acute Respiratory Distress Syndrome
  • Dornase Alfa Inhalation Solution [Pulmozyme]
  • standard procedure
  • Paris, France
    Hôpital Fondation A. de Rotschhild
Dec 20, 2021

SARS-CoV 2, ARDS Trial in Columbia (Dornase Alfa Inhalation Solution)

Completed
Has Results
  • SARS-CoV 2
  • ARDS
  • Dornase Alfa Inhalation Solution
  • Columbia, Missouri
    University of Missouri Hospital and Clinics
Apr 12, 2021

Ocular GVHD, Dry Eye Trial in Chicago (rhDNase I, Vehicle)

Terminated
Has Results
  • Ocular Graft vs Host Disease
  • Dry Eye
  • Chicago, Illinois
  • +1 more
Aug 10, 2021

Covid19 Trial in Mobile (Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase), 0.9%sodium chloride)

Recruiting
  • Covid19
  • Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)
  • 0.9%sodium chloride
  • Mobile, Alabama
    University of South Alabama
May 26, 2021

COVID-19 Infection Trial in Hamilton, Montreal (rhDNase I)

Recruiting
  • COVID-19 Infection
  • rhDNase I
  • Hamilton, Ontario, Canada
  • +1 more
Jan 20, 2021

Sjogren's Syndrome, Cough Trial in Farmington (Dornase alfa, Saline)

Withdrawn
  • Sjogren's Syndrome
  • Cough
  • Farmington, Connecticut
    University of CT Health Center
Jan 13, 2020

Cystic Fibrosis, Fibrosis Trial in Russian Federation (Tigerase®, Pulmozyme®)

Completed
  • Cystic Fibrosis
  • Fibrosis
  • Tigerase®
  • Pulmozyme®
  • Barnaul, Altai Region, Russian Federation
  • +13 more
Jul 8, 2020

Healthy Subjects Trial in Groningen (JHL1922, dornase alfa)

Completed
  • Healthy Subjects
  • JHL1922
  • dornase alfa
  • Groningen, Netherlands
    JHL Biotech Investigational Site
Jan 5, 2020

Pleural Diseases Trial in Gainesville (Chest thoracoscopy, Chest fibrinolytic therapy, tPA)

Completed
  • Pleural Diseases
  • Chest thoracoscopy
  • +3 more
  • Gainesville, Florida
    University of Florida
Feb 19, 2020

COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +18 more
Jul 19, 2021

Cystic Fibrosis Trial in Columbus (Recombinant Human DNase (Pulmozyme), Placebos)

Completed
Has Results
  • Cystic Fibrosis
  • Recombinant Human DNase (Pulmozyme)
  • Placebos
  • Columbus, Ohio
    Nationwide Children's Hospital
Apr 18, 2019

Dry Eye Trial in Chicago (DNase, Vehicle)

Terminated
Has Results
  • Dry Eye
  • Chicago, Illinois
    Translational Clinic of Corneal Neurobiology laboratory, Illinoi
Jan 15, 2020

Pleural Empyema Trial in Canada (TPA (Tissue Plasminogen Activator), DNase, Placebo)

Completed
Has Results
  • Pleural Empyema
  • TPA (Tissue Plasminogen Activator)
  • +2 more
  • Calgary, Alberta, Canada
  • +5 more
Apr 6, 2020

Pleural Empyema Trial (VATS group, Drain and intrapleural therapy group)

Recruiting
  • Pleural Empyema
  • VATS group
  • Drain and intrapleural therapy group
  • Aarhus, Denmark
  • +2 more
Jan 31, 2023

Lung Transplant Infection, Lower Respiratory Tract Infection Trial in Melbourne (Dornase Alfa, Isotonic Saline.)

Completed
Has Results
  • Lung Transplant Infection
  • Lower Respiratory Tract Infection
  • Dornase Alfa
  • Isotonic Saline.
  • Melbourne, Victoria, Australia
    The Alfred
Jul 22, 2019

Cystic Fibrosis, Mucociliary Clearance Defect Trial in Iowa City, Columbia (Symptom driven performance of airway clearance,

Not yet recruiting
  • Cystic Fibrosis
  • Mucociliary Clearance Defect
  • Symptom driven performance of airway clearance
  • Continuous daily performance of airway clearance
  • Columbia, Missouri
    University of Missouri Hospital and Clinics
Dec 12, 2022